Talis Biomedical Corp (CIK: 0001584751) EDGAR, Information, Filings... CompaniesBIO.Com

Talis Biomedical Corp

Mailing address
230 CONSTITUTION DRIVE, MENLO PARK, Delaware, 94025
Phone
650-433-3000
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS
Filings
N/A

Talis Biomedical Corp (CIK: 0001584751) is an American company incorporated in the state of California. Head office is located at 230 CONSTITUTION DRIVE, MENLO PARK, California, 94025. Work in the industry 3826 - (CF Office: Office of Life Sciences) LABORATORY ANALYTICAL INSTRUMENTS. Talis Biomedical Corp is a public company and trade via Over-The-Counter (OTC).

Old names:

SlipChip Corp from 2013-20-Aug to 2017-17-Oct

Owner	Filings	Transaction Date	Type of Owner
Lukowiak Andrew A	0001988083	Aug-01-2023	officer: President, other: Chief Scientific Officer
Dreismann Heinrich	0001379372	May-19-2023	director
Markovich Rebecca	0001771379	Apr-21-2023	officer: Interim CFO
Cheong Raymond	0001844536	Mar-10-2023	director
BAKER JULIAN	0001087939	Jun-10-2022	director, 10 percent owner
BAKER FELIX	0001087940	Jun-10-2022	director, 10 percent owner
BAKER BROS. ADVISORS LP	0001263508	Jun-10-2022	director, 10 percent owner
Baker Brothers Life Sciences LP	0001363364	Jun-10-2022	director, 10 percent owner
667, L.P.	0001551139	Jun-10-2022	director, 10 percent owner
Baker Bros. Advisors (GP) LLC	0001580575	Jun-10-2022	director, 10 percent owner
Blaser Brian J	0001492289	Dec-01-2021	director, officer: President and CEO
HILLEMAN JERYL L	0001216628	Mar-16-2021	director
Popovits Kimberly J	0001333482	Feb-11-2021	director
Scott Randal W.	0001337801	Feb-11-2021	director
Moody John Roger Jr	0001416843	Feb-11-2021	officer: Chief Financial Officer
Posard Matthew L.	0001543792	Feb-11-2021	director
Coe Brian	0001845260	Feb-11-2021	director, officer: Chief Executive Officer
Ismagilov Rustem F.	0001845273	Feb-11-2021	director
Gilliam Melissa	0001845279	Feb-11-2021	director
Liu Douglas	0001845307	Feb-11-2021	officer: Sr. Vice President, Operations
Flick Karen E.	0001845357	Feb-11-2021	officer: Chief of Staff, Sr. VP, Legal
Ramakrishnan Ramesh	0001845434	Feb-11-2021	officer: Sr. Vice President, R&D
Kelley Robert J.	0001845542	Feb-11-2021	officer: Chief Commercial Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Talis Biomedical Corp

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-24-107750 (34 Act) Size: KB	Oct-10-2024	005-92293 241365764
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-24-228320 (34 Act) Size: KB	Sep-30-2024	001-40047 241336450
25-NSE	Document	Acc-no: 0001354457-24-000710 (34 Act) Size: KB	Sep-20-2024	333-252360
8-K	Document	Current report filing Acc-no: 0000950170-24-107278 (34 Act) Size: KB	Sep-17-2024	001-40047 241304373
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000950170-24-104791 (33 Act) Size: KB	Sep-09-2024	333-261267 241287687
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000950170-24-104790 (33 Act) Size: KB	Sep-09-2024	333-273889 241287686
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000950170-24-104786 (33 Act) Size: KB	Sep-09-2024	333-266470 241287649
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0000950170-24-104784 (33 Act) Size: KB	Sep-09-2024	333-253218 241287637
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001373604-24-000088 ( Act) Size: 0 KB	Sep-09-2024
8-K	Document	Current report filing Acc-no: 0000950170-24-104396 (34 Act) Size: KB	Sep-06-2024	001-40047 241284626
8-K/A	Document	Amendment to Current report filing Acc-no: 0000950170-24-104090 (34 Act) Size: KB	Sep-05-2024	001-40047 241282144
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001373604-24-000086 ( Act) Size: 0 KB	Sep-05-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001373604-24-000084 ( Act) Size: 0 KB	Sep-04-2024
8-K	Document	Current report filing Acc-no: 0000950170-24-102921 (34 Act) Size: KB	Sep-03-2024	001-40047 241274998
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001373604-24-000081 ( Act) Size: 0 KB	Aug-28-2024
8-K	Document	Current report filing Acc-no: 0000950170-24-100200 (34 Act) Size: KB	Aug-23-2024	001-40047 241236604
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-098525 (34 Act) Size: KB	Aug-19-2024	001-40047 241220664
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001373604-24-000077 (34 Act) Size: KB	Aug-14-2024	005-92293 241210408
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001373604-24-000075 ( Act) Size: 0 KB	Aug-14-2024
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001373604-24-000069 (34 Act) Size: KB	Aug-14-2024	005-92293 241210295

Recent 20 filings. View all Talis Biomedical Corp filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Talis Biomedical Corp overview
Talis Biomedical Corp job
Talis Biomedical Corp stock
Talis Biomedical Corp ownership
Talis Biomedical Corp CEO
Talis Biomedical Corp documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.